ReviewFrontiers in cell and developmental biology2026
Extracellular vesicles in wound healing and scar formation: molecular regulation of macrophages, fibroblasts, and their crosstalk.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) mediate communication between immune and stromal cells during cutaneous repair by transferring proteins, lipids, nucleic acids, and other bioactive components. This review examines their effects on macrophage inflammatory and stress-adaptation programs, fibroblast activation and fate, and macrophage-fibroblast crosstalk in wound healing and pathological scarring. In chronic and metabolically impaired wounds, stem- and stromal-cell EVs commonly reduce persistent inflammation, improve macrophage autophagy and redox balance, and support fibroblast migration, proliferation, survival, and provisional matrix formation. In scar models, some EV preparations attenuate sustained profibrotic and mechanotransduction signaling, whereas EVs from diseased or microenvironmentally conditioned cells can prolong inflammation, maintain myofibroblast activity, and increase collagen deposition. Direct evidence for EV-mediated crosstalk is less extensive than evidence for effects on either cell type alone but supports communication in both directions. Macrophage-derived EVs alter fibroblast metabolism, growth signaling, autophagy, and extracellular matrix (ECM) production through long noncoding RNAs, microRNAs, and chemokines. Fibroblast-derived EVs can coordinate phase-specific macrophage responses during repair, whereas EVs from diabetic ulcers or fibrotic skin may impair macrophage autophagy, activate inflammasome signaling, and reinforce profibrotic feedback. EV activity therefore depends on the state of both donor and recipient cells, the local matrix and metabolic environment, dose, and timing. Particular emphasis is placed on reciprocal EV-mediated macrophage-fibroblast signaling, an aspect of cutaneous repair that remains insufficiently synthesized despite increasing mechanistic evidence. Clinical translation will require causal validation of EV transfer, standardized product characterization, and long-term assessment of wound closure and scar quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.